Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$391M |
| 2 |
Amazon
AMZN
|
+$361M |
| 3 |
Microsoft
MSFT
|
+$358M |
| 4 |
Meta Platforms (Facebook)
META
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$141M |
| 3 |
Eli Lilly
LLY
|
+$125M |
| 4 |
Waste Management
WM
|
+$124M |
| 5 |
McDonald's
MCD
|
+$112M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Thermon Group Holdings
THR
$823M
| $1.25M | ﹤0.01% |
73,200
-2,600
| -3% | -$44.3K |
|
2377
Flushing Financial
FFIC
$465M
| $1.24M | ﹤0.01% |
58,023
| – | – |
|
2378
DXP Enterprises
DXPE
$1.79B
| $1.24M | ﹤0.01% |
37,300
-900
| -2% | -$30K |
|
2379
Ennis
EBF
$463M
| $1.24M | ﹤0.01% |
57,500
-1,700
| -3% | -$36.6K |
|
|
ICPT
2380
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.24M | ﹤0.01% |
61,900
+2,200
| +4% | +$43.9K |
|
2381
Telos
TLS
$459M
| $1.24M | ﹤0.01% |
+36,300
| New | +$1.24M |
|
2382
BioXcel Therapeutics
BTAI
$52.1M
| $1.23M | ﹤0.01% |
2,650
+562
| +27% | +$261K |
|
|
HGEN
2383
DELISTED
HUMANIGEN, INC.
HGEN
| $1.23M | ﹤0.01% |
+70,900
| New | +$1.23M |
|
2384
Arrow Financial
AROW
$480M
| $1.23M | ﹤0.01% |
37,364
-1,311
| -3% | -$43.1K |
|
2385
Cass Information Systems
CASS
$563M
| $1.23M | ﹤0.01% |
30,152
+2,100
| +7% | +$85.6K |
|
|
WTRE
2386
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $1.23M | ﹤0.01% |
35,100
-3,100
| -8% | -$108K |
|
2387
Barrett Business Services
BBSI
$1.18B
| $1.23M | ﹤0.01% |
67,600
-1,600
| -2% | -$29K |
|
2388
Akebia Therapeutics
AKBA
$785M
| $1.22M | ﹤0.01% |
321,485
+7,700
| +2% | +$29.2K |
|
2389
V2X
VVX
$1.73B
| $1.22M | ﹤0.01% |
25,600
-700
| -3% | -$33.3K |
|
2390
GoHealth
GOCO
$76.1M
| $1.22M | ﹤0.01% |
7,240
+893
| +14% | +$150K |
|
2391
Curis
CRIS
$22.5M
| $1.22M | ﹤0.01% |
+7,530
| New | +$1.22M |
|
2392
Midland States Bancorp
MSBI
$384M
| $1.21M | ﹤0.01% |
46,100
| – | – |
|
2393
Tootsie Roll Industries
TR
$2.88B
| $1.21M | ﹤0.01% |
40,165
-6,866
| -15% | -$207K |
|
2394
PC Connection
CNXN
$1.6B
| $1.2M | ﹤0.01% |
26,000
-700
| -3% | -$32.4K |
|
2395
Mercer International
MERC
$206M
| $1.2M | ﹤0.01% |
94,372
-3,000
| -3% | -$38.2K |
|
2396
ImmunityBio
IBRX
$2.39B
| $1.2M | ﹤0.01% |
84,100
+9,600
| +13% | +$137K |
|
|
NWLI
2397
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.2M | ﹤0.01% |
5,349
-100
| -2% | -$22.4K |
|
2398
Kymera Therapeutics
KYMR
$3.12B
| $1.2M | ﹤0.01% |
24,700
-500
| -2% | -$24.3K |
|
2399
Comstock Resources
CRK
$4.59B
| $1.2M | ﹤0.01% |
+179,300
| New | +$1.2M |
|
2400
Kimball Electronics
KE
$726M
| $1.2M | ﹤0.01% |
55,000
-2,500
| -4% | -$54.4K |
|